Position in FTRE
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$8,058,904
-$1,815,358 QoQ
Shares Held
855,510
+49.5% QoQ
Ownership
0.904%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Allianz Asset Management GmbH holds $654,142,197 across 68 Biotechnology names. FTRE ranks #15 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
301,196 | $232,716,076 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
610,297 | $115,376,647 | |
| 3 | MRNA |
Moderna, Inc.
|
988,908 | $50,236,526 | |
| 4 | EXEL |
Exelixis, Inc.
|
954,551 | $40,940,690 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
400,020 | $22,597,128 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
1,441,683 | $20,846,736 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
47,662 | $15,769,925 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
706,664 | $15,730,340 |
All Filings in FTRE
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,058,904 | 855,510 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $9,874,262 | 572,421 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $2,568,167 | 305,008 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $1,255,283 | 254,106 | Shares | Defined | 2025-07-28 | |
| 2025-03-31 | $440,920 | 58,400 | Shares | Defined | 2025-05-05 | |
| 2024-12-31 | $363,675 | 19,500 | Shares | Defined | 2025-02-03 | |
| 2024-09-30 | $352,000 | 17,600 | Shares | Defined | 2024-11-13 | |
| 2023-09-30 | $271,204 | 9,486 | Shares | Defined | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||